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CLINICAL EVALUATION OF THE EFFECT OF PANFURAN－S
   FOR ACUTE CYSTITIS BY DOUBLE BLIND METHOD
Hiroshi KAwAi， Yoshio IKi， Toshimitsu KoNziKi，
    Bansui CHiN and Yoshizo NAKAGAMi
  The clinical effects of Panfuran－S （test drug abbreviated as FT） on acute sirnple cystitis
were studied by the double blind method with cephalexin （CEX） as the control drug．
  The total number of subjects was 107 cases， of which 81 cases could by evaluated about
the effects on the 4th day， 74th cases on the 7th day．
  In the separate evaluation of subjective symptoms， leukocytes in urine and bacteria in
urine （rnicroscopy． ） on the 4th and 7th day， there was no significant difference between the
FT and the CEX group．
  Clinical effects totally evaluated according to the criteria on subjective symptoms， leu－
kocytes in urine and bacteria in urine on the 4th and 7th day showed no significant dif－
ference between the FT and the CEX group．
  The eracacy rates of FT on 4th and 7th day were 70．0／Oof and 71．8％．， and that of CEX
were 85．0％ and 91．4％ respectively．
  Most of clinically isolated strains were E． coli． ln the relation of clinical effects to the
disc sens’itivity to E． coli on the 4th day， no significant difference was observed between the
FT and the CEX group．
  Side effects （gastrointestinal disorders） were observed in 26％ of the FT and in 14％ of
the CEX group， but according to hematological and blood chemistry findings before and after’
administration of FT and CEX， no disorders caused by drugs were observed．
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投 与 前 第  4  病  日
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投 与 前 第 7  病  日
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 また，FT 39例， CEX 35例について第7三日を比
Table 7．尿中白血球に対する効果（第4二日）
白血























@  N．S．計 23 12 1729 0  0 81 4  1 5  5 32・・181
Table 8．尿中白血球に対する効果（第7二日）
白血
 球 投 門 前 第  フ 病  日
薬剤




























して，FT 40例， CEX 41例について，投与前の分布
および第4病日の効果について両剤間で比較すると















細菌 投 与 前 第  4  病  日


















@ N．S．計 1i3941O ○ 81 ○ 7     11      0     63     81
Table 10．尿中細菌（検鏡）に対する効果（第7病日）
投    与   前 第  7  病  日 細菌









































  効果   1薬剤1二二撫二二検定備 考
大  腸  菌
変  形  菌
グラム陰性桿菌
肺炎桿菌
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